- we are not responsible for any errors or any use of information on our website, including testimonials - you should also not treat any information on our website as medical advice or as statements evaluated by the Food and Drug Administration, the Therapeutic Goods Administration or any other regulatory authority - you should not regard our products as being intended to diagnose, treat, cure or prevent any disease
Beyond its effects on muscle and fat, laboratory research has also highlighted additional benefits associated with this peptide combination
For patients whose primary issue is GH-axis-driven VAT accumulation rather than total caloric excess, tesamorelin may address the root cause more directly
Side Effects & Safety AOD-9604 has a genuinely clean safety profile based on both clinical studies and community use: Injection site reactions: Mild redness or bruising, common and temporary Headache: Reported by a minority of users in the first week, typically self-resolving Fatigue: Occasional, especially at higher doses usually resolves No significant hormonal disruption: Unlike full HGH, no thyroid, insulin, or IGF-1 concerns at standard doses AOD-9604 received GRAS (Generally Recognized As Safe) status from the FDA for use as a food ingredient during its development phase an unusual distinction that reflects its clean clinical safety data
